70 authors.
Molly WentDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Asta FörstiGerman Cancer Research Center, 69120, Heidelberg, Germany.
Britt-Marie HalvarssonHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
Niels WeinholdMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Scott KimberDivision of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
Mark van DuinDepartment of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
Gudmar ThorleifssondeCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
Amy HolroydDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Ni LiDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Giulia OrlandoDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Mina AliHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
Bowang ChenGerman Cancer Research Center, 69120, Heidelberg, Germany.
Jonathan S MitchellDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Rowan KuiperDepartment of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
Owen W StephensMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Uta BertschGerman Cancer Research Center, 69120, Heidelberg, Germany.
Chiara CampoGerman Cancer Research Center, 69120, Heidelberg, Germany.
Hermann EinseleUniversity Clinic of Würzburg, 97080, Würzburg, Germany.
Walter A GregoryClinical Trials Research Unit, University of Leeds, Leeds, LS2 9PH, UK.
Urban GullbergHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
Jens HillengassDepartment of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
Per HoffmannInstitute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
Graham H JacksonRoyal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
Karl-Heinz JöckelInstitute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, D-45147, Germany.
Ellinor JohnssonHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
Sigurður Y KristinssonDepartment of Hematology, Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland.
Ulf-Henrik MellqvistSection of Hematology, Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden.
Hareth NahiCenter for Hematology and Regenerative Medicine, SE-171 77, Stockholm, Sweden.
Alison DunningCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Julian PetoDepartment of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
Anthony SwerdlowDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Zsofia Kote-JaraiDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
PRACTICAL consortium
Jolanta NickelDepartment of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
Markus M NöthenInstitute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
Thorunn RafnardeCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
Fiona M RossWessex Regional Genetics Laboratory, University of Southampton, Salisbury, SP2 8BJ, UK.
Miguel Inacio da Silva FilhoGerman Cancer Research Center, 69120, Heidelberg, Germany.
Hauke ThomsenGerman Cancer Research Center, 69120, Heidelberg, Germany.
Ingemar TuressonHematology Clinic, Skåne University Hospital, SE-221 85, Lund, Sweden.
Annette VangstedDepartment of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
Niels Frost AndersenDepartment of Haematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000, Aarhus C, Denmark.
Anders WaageDepartment of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway.
Brian A WalkerMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Anna-Karin WihlborgHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
Annemiek BroylDepartment of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
Faith E DaviesMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Unnur ThorsteinsdottirdeCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
Christian LangerDepartment of Internal Medicine III, University of Ulm, D-89081, Ulm, Germany.
Hartmut GoldschmidtDepartment of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
Martin KaiserDivision of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
Pieter SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
Kari StefanssondeCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
Gareth J MorganMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Kari HemminkiGerman Cancer Research Center, 69120, Heidelberg, Germany. K.Hemminki@dkfz-heidelberg.de.
Björn NilssonHematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.